What is Sheryl L. Conley’s Neuronetics (STIM) share ownership after this RSU grant?

Following the reported RSU award, Conley directly holds 251,716 shares of Neuronetics common stock. This figure reflects her direct ownership position as shown in the Form 4 after accounting for the newly granted restricted stock units.

Neuronetics (STIM) director Sheryl Conley awarded 30,000 RSUs in stock grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CONLEY SHERYL L reported acquisition or exercise transactions in this Form 4 filing.

Neuronetics, Inc. director Sheryl L. Conley reported receiving an equity award in the form of restricted stock units. The award covers 30,000 RSUs, with no cash purchase price. Each RSU represents the right to receive one share of Neuronetics common stock.

The RSUs vest on the earlier of May 28, 2027, or her Board-approved separation from service or a change in control of Neuronetics, in each case conditioned on her continuous service through that date. After this grant, Conley holds 251,716 shares of common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CONLEY SHERYL L

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	--

Holdings After Transaction: Common Stock — 251,716 shares (Direct, null)

Footnotes (1)

Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Key Figures

RSU grant size: 30,000 units Transaction price per share: $0.0000 per share Post-grant holdings: 251,716 shares +2 more

5 metrics

RSU grant size 30,000 units Restricted stock unit award to director on May 28, 2026

Transaction price per share $0.0000 per share Reported grant price for RSU award

Post-grant holdings 251,716 shares Total common shares directly held after transaction

RSU-to-share ratio 1 RSU : 1 share Each RSU represents one share of common stock

RSU vesting date May 28, 2027 Vests on earlier of this date, Board-approved separation, or change in control

Key Terms

restricted stock unit ("RSU"), change in control, continuous service

3 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award that vests on the earlier"

change in control financial

"separation of service from the Issuer or change in control of the Issuer"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

continuous service financial

"in each case subject to continuous service of the Reporting Person through such date"

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 05:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CONLEY SHERYL L

(Last)

(First)

(Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN

PENNSYLVANIA

19355

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/28/2026		A		30,000⁽¹⁾	A	$0⁽²⁾	251,716	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.

2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	/s/ Francis Brown, as Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Neuronetics (STIM) director Sheryl L. Conley report in this Form 4?

Sheryl L. Conley reported receiving an award of 30,000 restricted stock units from Neuronetics. This is a stock-based compensation grant, with each RSU representing a contingent right to receive one share of Neuronetics common stock at vesting.

How many shares are covered by Sheryl L. Conley’s new RSU award at Neuronetics (STIM)?

The RSU grant covers 30,000 units, each equal to one share of common stock. When vested, these RSUs can deliver up to 30,000 Neuronetics shares, subject to the vesting and service conditions described in the Form 4 footnotes.

When do Sheryl L. Conley’s Neuronetics (STIM) RSUs vest?

The RSUs vest on the earlier of May 28, 2027, or her Board-approved separation or a change in control of Neuronetics. In each case, vesting requires her continuous service with the company up to the applicable vesting date.

Does Sheryl L. Conley pay a purchase price for the Neuronetics (STIM) RSU grant?

No cash purchase price is indicated for this RSU grant; the transaction price per share is reported as 0.0000. The award is stock-based compensation, not an open-market purchase of Neuronetics common stock by the director.